Target intelligence / Profile preview

WW domain binding protein 11 pseudogene

Molecular classification: Pseudogene

Overview

The WW domain binding protein 11 pseudogene represents a non-functional, typically non-coding genomic sequence derived by duplication or retrotransposition from the protein-coding WBP11 gene. While WBP11 encodes a nuclear protein involved in mRNA splicing and cell division processes, its pseudogene, as referenced by ENSG00000271338, lacks functional protein-coding capability and is not known to have direct biological, disease, or therapeutic significance[6][7]. Pseudogenes are important from an evolutionary perspective and sometimes may participate in gene regulation, but there are no specific roles attributed to this particular pseudogene.

Other names: WBP11P1HsT3017

Beyond the preview

Go deeper on WW domain binding protein 11 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WW domain binding protein 11 pseudogene.

Explore the full profile